All News

From ballooning ankles to rashes, there were multiple chemotherapy side effects that I had to deal with — here’s how I did it.

Improvements may not be seen right away, but patients with non-metastatic breast cancer should stay compliant to practicing yoga to possibly improve quality of life, according to an expert.

Krazati was granted an accelerated approval for patients with KRAS G12C-mutant locally advanced or metastatic non-small cell lung cancer, according to the Food and Drug Administration.

Watch Dr. Jamile M. Shammo, from Northwestern University Feinberg School of Medicine, discuss current treatment options in polycythemia vera during the CURE Educated Patient MPN Summit.

During the holiday season, immunocompromised people, particularly patients with cancer, may have an increased risk for getting COVID-19. An expert shares tips on how to have safe and enjoyable family gatherings.

CURE® took a look at the most popular and practice-changing breast cancer news from 2022. Here’s what we found.

Men often decide to tough out their cancer alone, but tough guy Terry Bradshaw is starting to open up about his sometimes-rocky journey with the disease.

CURE®’s Multiple Myeloma Heroes® Award Program honors and gives thanks to those who have made it their mission to change the lives of patients with multiple myeloma.

Tecentriq was approved by the FDA for adults and children aged two years and older with advanced alveolar soft part sarcoma, a disease typically diagnosed in approximately 80 patients per year in the U.S.

Watch Dr. Douglas A. Tremblay, from Mount Sinai, discuss treatment for essential thrombocythemia during the CURE Educated Patient MPN Summit.

Watch Dr. Aaron T. Gerds, from Cleveland Clinic Taussig Cancer Institute, discuss essential thrombocythemia risk during the CURE Educated Patient MPN Summit.

Lifileucel, a personalized adoptive tumor-infiltrating lymphocyte therapy, showed promising responses in patients with pretreated melanoma, according to cohort findings from a recent clinical trial.

From fertility issues to oral side effects, cancer survivors may face health complications after treatment ends.

Once I got the hang of administering subcutaneous immunoglobulin, my life was so much easier, as I no longer had to undergo monthly IV infusions for my cancer-related compromised immune system.

From the death of a Broadway actor to TV stars completing treatment, here’s what’s happening in the cancer space this week.

Watch Dr. Francesco Maura, Dr. Marcella Kaddoura and Mary DeRome answer questions about the future of myeloma during the CURE® Educated Patient® Multiple Myeloma Summit.

Patients with breast cancer, regardless of their menopausal status, may face worse cognitive ability with chemotherapy and endocrine therapy, although this may return to its pretreatment level after 36 months.

Robert Atteberry never gave up, even after three cancer diagnoses, and has found a motivation and passion for competing in triathlons during survivorship.

I am not allowed to use CBD products, so when my oncology team recommended I try them, it gave me pause.

After Marshall Morris was diagnosed with a rare cancer and given only six months to live, he created a charity that empowers people with terminal illness and provides them with counseling and support.

Watch Dr. Marcella Kaddoura, from Miami Sylvester Comprehensive Cancer Center, discuss targeting myeloma with small molecules with precision medicine during the CURE® Educated Patient® Multiple Myeloma Summit.

Recent research sought to determine which patients with HR-positive breast cancer can benefit by adding ovarian function suppression to their adjuvant regimens, and which patients can skip it.

It is important for survivors to maintain healthy oral hygiene because they face increased risk of dental problems.

Years after I went through mesothelioma, my husband was diagnosed with cancer, causing a reversal in the patient-caregiver roles.

Study findings showed that anxiety and depression may not decrease over time in patients with testicular cancer, emphasizing the importance of discussing symptoms with cancer teams.

Watch Dr. Francesco Maura, from Miami Sylvester Comprehensive Cancer Center, discuss how personalized prediction models can be used to identify the best treatments during the CURE® Educated Patient Multiple Myeloma Summit.

Children with acute lymphoblastic leukemia had a 2.4-fold greater risk of relapse if they were considered extremely obese while undergoing maintenance therapy.

The internet is flooded with information for cancer survivors, and it is vital they recognize the reliable sources from those that are not.